Safety of tenofovir use during pregnancy
George K. Siberry(Columbia University Irving Medical Center), D. Heather Watts(National Institutes of Health), Paige L. Williams(Cancer Research And Biostatistics), Linda A. DiMeglio(Urology of Indiana), Kenneth Rich(University of Illinois Chicago), Lynne Mofenson(Elizabeth Glaser Pediatric AIDS Foundation), Deborah Kacanek(Cancer Research And Biostatistics), Raymond Griner(Cancer Research And Biostatistics), Hermann Mendez(State University of New York), Katherine Tassiopoulos(Harvard University), Tracie L. Miller(University of Missouri–Kansas City), George R. Seage(Unknown), Rohan Hazra, Denise L. Jacobson(Cancer Research And Biostatistics)
Cited by 138
Related Papers
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
|The Lancet|1999|1.7k
Combination Antiretroviral Strategies for the Treatment of Pregnant HIV-1–Infected Women and Prevention of Perinatal HIV-1 Transmission
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2002|896
Combination Antiretroviral Strategies for the Treatment of Pregnant HIV-1–Infected Women and Prevention of Perinatal HIV-1 Transmission
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2002|697
Measles Antibody: Reevaluation of Protective Titers
|The Journal of Infectious Diseases|1990|612